Login / Signup

Across the blood-brain barrier: Neurotherapeutic screening and characterization of naringenin as a novel CRMP-2 inhibitor in the treatment of Alzheimer's disease using bioinformatics and computational tools.

Maryam LawalFisayo A. OlotuMahmoud E. S. Soliman
Published in: Comput. Biol. Medicine (2018)
Keyphrases